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Introduction {#sec1}
============

Tissue-specific gene expression programs are established by the temporal activation and selective repression of genes during development. Transcription factors play a pivotal role in this process because of their inherent ability to bind specific DNA sequences in the regulatory regions of genes ([@bib19]). Higher-order nucleosome structures impede transcription factor binding. During development, the initial opening of the compacted nucleosomal structures is mediated by a special subset of transcription factors, called pioneer factors ([@bib5], [@bib6], [@bib4], [@bib12]). Pioneer factors, such as FoxA and GATA factors, have an intrinsic ability to bind DNA embedded in closed chromatin and remodel adjacent nucleosomal areas ([@bib49]).

Following pioneer factor-mediated chromatin opening, the exposed regions are accessed by other regulators, which activate transcription via the recruitment of the transcription apparatus ([@bib13], [@bib32], [@bib23]). Binding of multiple additional transcription factors to promoters is important for the execution of stable gene expression programs, as evidenced by the functional redundancy of many hepatic transcription factors, including FoxA pioneer factors ([@bib22], [@bib18]). Thus, following initial opening, binding of other non-pioneer transcription factors may contribute to the stabilization and maintenance of open chromatin structures and the acquisition of transcription competency.

Although transcription regulation during the early hepatocyte specification stage and in late adult stages has been extensively studied, the molecular events shaping active promoter configuration during the intervening periods are less well understood. To address this issue, we studied the temporal patterns of HNF4α and C/EBPα binding to regulatory regions from embryonic day (E) 15.5, a stage long after the time of early hepatic specification (E7.5--E9.0) when pioneer factors first engage with genomic regions to adulthood, when hepatocytes are fully differentiated.

Results and Discussion {#sec2}
======================

HNF4α and C/EBPα Binding to Regulatory Regions Is Highly Dynamic during Liver Development {#sec2.1}
-----------------------------------------------------------------------------------------

HNF4α and C/EBPα are prominent hepatic transcription factors required for the activation of most hepatic genes, but they lack pioneer factor features, such as high-affinity binding to compacted nucleosomes and an ability to open condensed chromatin ([@bib41]; [@bib20], [@bib30], [@bib18], [@bib7]). Consistent with the large number of genes they regulate, we detected significantly higher levels of histone H3 lysine 27 acetylation (H3K27ac) active histone modification marks or RNA polymerase II (RNA Pol II) associations in HNF4α and C/EBPα-bound promoters, compared with those not occupied by them ([Figure S1](#mmc1){ref-type="supplementary-material"}A).

Liver transcriptomes during mouse development displayed significant variations ([Figure 1](#fig1){ref-type="fig"}A). This was expected, given the primary role of the liver in homing hematopoietic cells during embryogenesis and the gradual acquisition of differentiated hepatocyte functions, such as metabolism and detoxification in postnatal life ([@bib39]). Interestingly, we also observed great variations in the genome-wide occupancy patterns of C/EBPα and HNF4α during development ([Figure 1](#fig1){ref-type="fig"}A). Evaluation of the binding profiles revealed that less than 25% of the binding locations were bound continuously by C/EBPα or HNF4α from E15.5 and onward ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}B). Binding to other locations was either lost during development (loss) or first appeared at E18.5 or later and remained bound afterward (gain), while more than half of the binding events were temporary (transient) ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}B). These latter patterns are inconsistent with the current view that composite promoter structures are built stepwise during development and they cannot be reconciled with the developmental variations in gene expression patterns.Figure 1Most Individual C/EBPα and HNF4α Binding Events Are Highly Dynamic during Development and Poorly Correlate with Transcription(A) Multidimensional scaling analysis (MDS) of mRNA levels and C/EBPα and HNF4α binding during development. mRNA sequencing (mRNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq) data are from embryonic days 15.5 (E15) and 18.5 (E18), newborn mice (P0), and P14, P22, or P60, as indicated.(B) Summary of temporal patterns of C/EBPα and HNF4α binding during liver development. Bars correspond to the number of peaks present constantly and those of loss, gain, and transient categories, as detailed in [Figure S1](#mmc1){ref-type="supplementary-material"}. Numbers in parentheses correspond to numbers of genes associated with the peaks.(C) Binding signal heatmaps of individual C/EBPα binding locations within the +1 to −10 kb regions of genes, and corresponding clustering of RNA Pol II and H3K27ac signals around the binding sites at the indicated developmental times. Numbers of genes in the four clusters (A, B, C, and D) are shown at left.(D) Violin plots for comparisons of the steady-state mRNA levels of genes in the gene clusters in (C).(E) TIP score analysis of C/EBPα binding events. Top panels show relative mRNA levels of genes ranked by the C/EBPα regulatory potential scores (shown in the bottom panels), as calculated by the TIP method.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Transcription Factor Binding Dynamics Poorly Correlate with Gene Activation Timing {#sec2.2}
----------------------------------------------------------------------------------

Analyses of the H3K27ac profiles and those of RNA Pol II occupancy around the binding sites revealed that more than half of C/EBPα or HNF4α binding locations were not clustered with active chromatin regions ([Figures 1](#fig1){ref-type="fig"}C, 1D, [S1](#mmc1){ref-type="supplementary-material"}C, and S1D). The poor correlation between individual binding events and transcriptional activity is supported by the relatively low regulatory score values at different developmental stages, which was calculated by the probabilistic method target identification from profiles (TIP) ([@bib3]; [Figures 1](#fig1){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}E).

Next, we analyzed the temporal mRNA profiles of the genes occupied constantly or dynamically by C/EBPα or HNF4α. Surprisingly, gene activation patterns did not correlate with the patterns of C/EBPα or HNF4α binding in dynamically occupied genes (i.e., loss, gain, and transient categories) ([Figure 2](#fig2){ref-type="fig"}A). Most of these dynamically occupied genes were either never activated or activated at some time point but in a manner different from the temporal pattern of transcription factor binding. In contrast, more than half of the constantly occupied genes were expressed continuously from E15.5 to adulthood ([Figure 2](#fig2){ref-type="fig"}A, panels at left). Even in this latter group, about one-third of the genes was never activated during the time frame of our analyses, supporting the notion that individual transcription factor binding events poorly correlate with transcription activation. Thus, early and persistent binding is necessary, but not sufficient, for developmental gene activation.Figure 2Combinatorial Constant and Dynamic Binding Events Correlate with Progressive Broadening of Active Chromatin Domains(A) Temporal patterns of gene expression with different C/EBPα and HNF4α binding kinetics. The panels represent genes according to the binding patterns specified in [Figure 1](#fig1){ref-type="fig"}B, as indicated at the top. Bars indicate the total number of genes and genes never activated during the period between E15 and P60; "genes activated" are genes that were active at one or more time points, and "activation correlates with binding" represent genes that were active at the same time points when C/EBPα or HNF4α occupied them.(B) Distribution and number of genes with single and multiple constant or dynamic binding events.(C and D) Average H3K27ac (C) and average RNA Pol II (D) coverage profiles of constantly bound genes at different stages of development.(E) Number of SEs formed on constantly bound genes at different developmental times.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Combinatorial Binding by Multiple Factors Is Required for Gene Activation {#sec2.3}
-------------------------------------------------------------------------

To understand the mechanisms of different binding dynamics, we searched for potential sequence variants in the binding locations, which may influence the stability of interactions. A *de novo* binding motif search did not reveal major sequence variations in the occupied loci at the different stages of development and/or in loci occupied constantly or dynamically ([Figures S1](#mmc1){ref-type="supplementary-material"}F and S1G).

To evaluate the binding characteristics more precisely, we plotted the kernel density profiles of the normalized C/EBPα or HNF4α reads under the corresponding regions. As shown in [Figure S2](#mmc1){ref-type="supplementary-material"}A, we often observed broad, bimodal density profiles, characteristic of factors possessing high affinity-high occupancy and low affinity-low occupancy locations in the genome ([@bib26]). The non-unimodal kernel density profiles raised the possibility that regulatory regions are occupied at multiple locations by C/EBPα or HNF4α, with variable stability and residence time.

This scenario was confirmed by analysis of the occupancy patterns of constantly bound genes, which are activated at some point during development (1,277 genes bound by C/EBPα and 1,525 genes bound by HNF4α). Only small fractions of these genes are occupied at a single location (79 and 53 genes, respectively) ([Figure 2](#fig2){ref-type="fig"}B). Most of them were occupied at multiple locations, in 2 to 8 sites. Most additional binding events were dynamic (i.e., gain or transient). Importantly, the number of genes for which the additional binding events correspond to binding of a different factor (C/EBPα or HNF4α, 995 + 21 or 1,341 + 20 genes, respectively) far outweighs the number of genes occupied by a single factor at multiple sites (103 + 79 for C/EBPα-bound genes and 56 + 55 for HNF4α-bound genes) ([Figure 2](#fig2){ref-type="fig"}B). Thus, combinatorial stable and dynamic binding by multiple transcription factors is a common feature of most developmentally activated promoters.

Progressive Broadening of Active Chromatin Domains during Development {#sec2.4}
---------------------------------------------------------------------

Although about half of the constantly bound genes, i.e., those occupied continuously from E15.5 and onward, were also active transcriptionally from E15.5, their absolute expression levels were increased during development. This was also evident from the gradual increase of H3K27ac and RNA Pol II occupancy levels ([Figures 2](#fig2){ref-type="fig"}C and 2D). Examination of individual regions revealed a continuous spreading of the areas with H3K27-acetylated nucleosomes, which correlated with the increase of RNA Pol II occupancy levels ([Figure S2](#mmc1){ref-type="supplementary-material"}B). To obtain quantitative comparisons between the lengths of the H3K27-acetylated areas, we used the computational method for super enhancer (SE) identification ([@bib47]; [Figure S2](#mmc1){ref-type="supplementary-material"}C). The number of such SE regions in constantly bound genes was steadily increased during development ([Figure 2](#fig2){ref-type="fig"}E), pointing to a strong connection between developmental gene activation and transcription factor-mediated progressive broadening of active chromatin domains.

Next, we repeated our analysis focusing on the C/EBPα- or HNF4α-occupied genes that were highly active in adult liver. A ranked plot of the average normalized reads of genes with reads per gene length (RPGL) values \> 0.5 at postnatal day (P) 60 (2,704 genes) showed that the average mRNA levels of these genes continuously increased during development ([Figure 3](#fig3){ref-type="fig"}A). RNA Pol II occupancy and H3K27ac in promoters and gene bodies positively correlated with the changes in mRNA levels ([Figures 3](#fig3){ref-type="fig"}B and 3C). Similar to the constantly bound genes, single binding events were rare ([Figure 3](#fig3){ref-type="fig"}D). A minor portion of the genes were occupied by the same factor at multiple locations (8 + 60 bound by C/EBPα and 1 + 43 bound by HNF4α). In these promoters, the binding mode of the additional factor or factors was mainly dynamic. Most (552 + 1,917) of the genes were occupied by both C/EBPα and HNF4α ([Figure 3](#fig3){ref-type="fig"}D, panels at right) and 77% of them (1,917 genes) were occupied dynamically by the additional factors. Representative binding profiles of the latter most common gene category are shown in [Figure S2](#mmc1){ref-type="supplementary-material"}B. The preceding findings support the model that combinatorial binding of multiple transcription factors from the earliest developmental time point of this study is accompanied by highly dynamic additional binding events and the parallel appearance of H3K27-acetylated nucleosomes. During this process, H3K27-acetylated regions are progressively expanded, which correlates with a gradual increase in RNA Pol II occupancy.Figure 3Early Bookmarking of Developmentally Activated Genes by C/EBPα and HNF4α(A) Ranked coverage plots of relative mRNA levels of genes active at P60 (i.e., RPGL \> 0.5) at different developmental time points.(B and C) Average RNA Pol II (B) and average H3K27ac (C) coverage profiles of genes active at P60 during development.(D) Distribution and number of genes active at P60 with single and multiple constant or dynamic (arrows) binding events.(E) Average relative mRNA levels of genes activated at E18 or later and the timing of C/EBPα or HNF4α binding relative to activation.(F) Number of the E18-activated, bookmarked genes, which were properly activated or not activated at E18 in C/EBPα-KO or HNF4α-KO mice.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

C/EBPα and HNF4α Bookmark Developmentally Induced Genes {#sec2.5}
-------------------------------------------------------

Gene activation and RNA Pol II association often occurred long after the first detectable recruitment of C/EBPα or HNF4α. Representative examples of genes that are activated 3 to 25 days after transcription factor binding are shown in [Figure S3](#mmc1){ref-type="supplementary-material"}A. To investigate this phenomenon, we studied the genes that were silent at E15.5 and were first activated at E18.5 or later. Among these genes, the mRNAs of 299 genes first appeared at E18.5. Likewise, we identified several genes that were first activated at P0, P4, P14, P22, or P60 ([Figure 3](#fig3){ref-type="fig"}E). More than half of these genes were occupied by C/EBPα or HNF4α. Importantly, most were bound by C/EBPα or HNF4α before transcription activation ([Figures 3](#fig3){ref-type="fig"}E, [S3](#mmc1){ref-type="supplementary-material"}A, and S3B).

To assess the functional importance of the early binding events, we tested their activation time in knockout mouse models devoid of C/EBPα or HNF4α from E15.5 or earlier. Because embryonic liver-specific inactivation of both C/EBPα and HNF4α leads to early lethality at birth ([@bib46], [@bib33], [@bib18]), we could examine only genes that were first activated at E18.5 livers. About 90% of the early-bound genes were not activated properly at E18.5 in C/EBPα- or HNF4α-deficient mice ([Figure 3](#fig3){ref-type="fig"}F), suggesting that early binding of transcription factors is required for future activation of the genes. We call this process developmental bookmarking, which may contribute to the maturation and spreading of open chromatin domains during development. Supporting this scenario is the progressive increase of H3K27-acetylated nucleosomes, RNA Pol II occupancy, and the formation broad open chromatin domains (SEs) at subsequent stages of development ([Figures 4](#fig4){ref-type="fig"}A--4C). Irrespective of developmental timing or the patterns of binding events, C/EBPα- or HNF4α-bound genes were enriched in pathways and Gene Ontology terms of metabolism-related processes, which is characteristic to differentiated hepatocytes ([Figure S3](#mmc1){ref-type="supplementary-material"}C). This is consistent with the scenario that these factors bookmark target genes, which will be activated later during development.Figure 4Broadening of Open Chromatin Domains in Bookmarked Genes and Bookmarking of Developmentally Silenced Genes(A and B) Average relative H3K27ac levels (A) and average RNA Pol II coverage profiles (B) of genes activated at different developmental stages after E15. Arrows indicate the time of activation.(C) Number of SEs formed on genes activated at different developmental time points after E15.(D--F) Average relative mRNA (D), H3K27ac (E), and H3K27me3 (F) levels in postnatally silenced hepatic genes during development. The red line indicates H3K27me3 levels in the olig2 gene region.(G) Postnatally silenced genes bound by C/EBPα or HNF4α. Retained binding corresponds to genes occupied by either C/EBPα or HNF4α until P60. Oncofetal genes correspond to the fraction of postnatally silenced genes whose expression is induced in DEN-induced liver tumors.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Analyses of the C/EBPα-bookmarked Asgr1, Vnn3, and Clec2d regulatory regions in wild-type and C/EBPα-deficient embryonic livers revealed reciprocal changes of the repressive heterochromatin-associated histone H3 lysine 27 trimethylation (H3K27me3) and the activation-associated histone H3 lysine 4 trimethylation (H3K4me3) histone modification marks ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4C). Thus, binding of transcription factors long before transcription activation may prevent heterochromatin spreading into genomic regions premarked for future activation.

C/EBPα and HNF4α Bookmark Genes Silenced after Birth {#sec2.6}
----------------------------------------------------

Several hepatic genes active during embryonic life are silenced following birth and may be reactivated under specific conditions in adulthood. We retrieved 529 genes from our RNA sequencing (RNA-seq) data that were active in embryonic stages and repressed postnatally ([Figure 4](#fig4){ref-type="fig"}D). A parallel decrease in H3K27ac levels was evident in these regions, although most enhancers near inactive genes retained a significant H3K27ac signal above background ([Figure 4](#fig4){ref-type="fig"}E) and did not acquire repressive H3K27me3 modification ([Figure 4](#fig4){ref-type="fig"}F). At least 224 of the genes whose expression was shut down after birth were bound by C/EBPα, HNF4α, or both in embryonic liver. C/EBPα and HNF4α remained associated in one or more locations in more than two-thirds of them following birth and throughout adulthood ([Figures 4](#fig4){ref-type="fig"}G, [S4](#mmc1){ref-type="supplementary-material"}D, and S4E). This raises a possible role for C/EBPα and HNF4α as gene-specific repressors. Some combination of HNF4α isoforms (e.g., HNF4α4-5-6) has been shown to function as repressor or activator in a gene-specific manner ([@bib17]). Although the antibodies used in our study cannot distinguish among HNF4α isoforms, an isoform-mediated repressive mechanism is unlikely, because mouse livers express mainly the HNF4α1-3 isoforms. Because C/EBPα and HNF4α occupy several promoters in both active (embryonic) and inactive (postnatal) states, their direct involvement in transcription activation-repression could only be explained by some kind of coactivator-corepressor exchange on their surface in the respective promoters. Although we cannot exclude this possibility, we favor the hypothesis that C/EBPα and HNF4α contribute to the formation of a multifactor activation complex, while under repressive conditions, they function as bookmarks for keeping the loci competent for future activation. The preceding two possibilities are not mutually exclusive.

Many of the preceding postnatally silenced genes, like Afp, H19, Pkm2, Igf2, Slc4a1, and GPC3, are known oncofetal genes that are reactivated in most hepatocellular carcinomas ([@bib1], [@bib27]). Using RNA-seq data from Diethylnitrosamine (DEN)-induced mouse liver cancer ([@bib36]), we retrieved 38 oncofetal genes that are bound by C/EBPα or HNF4α during embryonic life. In 20 of them, we could detect binding of C/EBPα, HNF4α, or both in one or more locations even at late postnatal stages (P60). These data demonstrate that transcription factor bookmarking may also play a role in keeping several developmentally silenced genes competent for future activation in specific conditions, such as cancer.

Conclusions {#sec2.7}
-----------

During development, pioneer transcription factors are the first to engage with gene regulatory regions. They destabilize tightly condensed chromatin to provide access for other transcription factors, which together with the pioneer factors facilitate the assembly of the preinitiation complexes and activate transcription ([@bib12]).

Our findings demonstrate that recruitment of the non-pioneer C/EBPα and HNF4α hepatic factors following pioneer factor-mediated specification is not necessarily linked to concomitant, immediate transcriptional activation. Most binding events are highly dynamic, while more persistent ones arise long before the activation of target genes during development. The substantial temporal interval between non-pioneer factor binding and gene activation points to their role as bookmarking factors, which premark and keep specific genomic regions competent for future activation. According to this model, before preinitiation complex assembly and transcription initiation, gene regulatory regions undergo a lengthy maturation process. Stable and dynamic association of transcription factors facilitates progressive expansion of active chromatin domains and in parallel prevents the deposition of repressive histone modification marks.

Transcription factor retention was also observed in genes silenced after birth. Because many of these genes can be reactivated under certain conditions (e.g., cancer) during adult life, we propose that bookmarking factors may in general function as gatekeepers for keeping silent genes competent for future reactivation.

The preceding phenomena are reminiscent of the previously described mitotic bookmarking function of transcription factors: part of pioneer and non-pioneer factors remains associated with chromatin during mitosis, when the genome becomes highly condensed and transcription is shut down or globally decreased to very low levels ([@bib2], [@bib31], [@bib32], [@bib44], [@bib8]). Upon entering the G1 phase, bookmarking factors can facilitate the rapid reestablishment of previous transcription patterns, thus ensuring maintenance of cell identity ([@bib32]). A significant portion of both C/EBPα and HNF4α remains associated with mitotic chromatin in cycling cells ([Figure S3](#mmc1){ref-type="supplementary-material"}D; [@bib2]), suggesting that they may also contribute to the propagation of regulatory information through mitosis.

Apart from the striking parallel between developmental and mitotic bookmarking, transcription factor binding dynamics during development employ remarkably similar principles to those operating during mammalian evolution. Individual C/EBPα or HNF4α binding events are not conserved in distantly or closely related mammalian species ([@bib37], [@bib42]). In analogy to their rapid binding turnover during evolution, we observed a highly dynamic association-dissociation with target sites during mouse liver development. Furthermore, evolutionary stability of gene expression requires combinatorial binding of multiple factors ([@bib42]), which, as shown here, is a fundamental feature of developmental gene activation.

Altogether, the temporal dynamics of transcription factor binding uncovered in this study suggest that gene activation mechanisms during development, cell-cycle progression, and evolution are shaped by common regulatory principles.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**C/EBPαSanta Cruz Biotech.Cat\# sc-9314; RRID:[AB_2078046](nif-antibody:AB_2078046){#interref165}C/EBPαCell SignalingCat\#8178; RRID:[AB_11178517](nif-antibody:AB_11178517){#interref195}HNF4αSanta Cruz Biotech.Cat\# sc8987; RRID:[AB_2116913](nif-antibody:AB_2116913){#interref170}HNF4αCell SignalingCat\#3113; RRID:[AB_2295208](nif-antibody:AB_2295208){#interref175}RNA-Pol-IIEuromedexPB-7G5H3K27Me3AbcamCat\#Ab6002; RRID:[AB_305237](nif-antibody:AB_305237){#interref180}H3K4Me3AbcamCat\#Ab8580; RRID:[AB_306649](nif-antibody:AB_306649){#interref185}Anti-rabbit IgG (H+L), F(ab') Alexa Fluor 594Cell SignalingCat\#8889; RRID:[AB_2716249](nif-antibody:AB_2716249){#interref190}**Chemicals, Peptides, and Recombinant Proteins**Complete, EDTA-free Protease Inhibitor CocktailRoche11873580001Proteinase KThermo Scientific17916Formaldehyde (37% solution)ApplichemA0877,0250DynaBeads Protein GInvitrogen10004DTrizol ReagentLife Technologies15596-026MMLV Reverse transcriptasePromegaM1701DNaseI recombinant, RNase-freeRoche04716728001Fast Start Universal SYBR Green MasterRoche10689400T4 DNA polymeraseNEBM0203LCollagenase ARoche101003578001Klenow fragmentNEBM0210LT4 DNA PNKNEBM0201LT4DNA Ligase BufferNEBB02025PEG8000PromegaV3011BSA Fraction IV Fatty acid freeSigma-Aldrich054822x Kapa HiFi hotstart Ready MixKapa BiosystemsKK2602Quick LigaseNEBM2200LKlenow 3′→5′ exo-NEBM0212LUSERNEBM5505SNEBNext adaptorNEBE7337ANEBNext Universal PCR Primer for IlluminaNEBE7336ANEBNext Index 1-12 Primers for IlluminaNEBE7331, E7339-E7349NEB Multiplex Oligos for IlluminaNEBE7335S**Critical Commercial Assays**MinElute columnsQIAGEN28604dsDNA HS Assay KitInvitrogenQ32851Agentcourt AMPUR XPBeckman CoulterA63881**Deposited Data**ChIP-seq data C/EBPαThis paperGSE137066ChIP-seq data RNA Pol-IIThis paperGSE137066ChIP-seq data HNF4αThis paperGSE137066RNA-seq data C/EBPα-KO and HNF4α-KOThis paperGSE137066**Experimental Models: Cell Lines**HuH7 cellsCreative BioarrayC9441L**Experimental Models: Organisms/Strains**C57BL/6J mouseJackson Laboratory000664HNF4 lox/lox[@bib9]PMID: [11158324](pmid:11158324){#intref0010}C/EBPα lox/lox[@bib11]PMID: [15292250](pmid:15292250){#intref0015}C57BL/6-Alfp-Cre[@bib14]PMID: [10686615](pmid:10686615){#intref0020}**Software and Algorithms**bwa[@bib51]N/Atophat2[@bib52]N/AFastQC<https://www.bioinformatics.babraham.ac.uk/projects/fastqc/>N/Abedtools[@bib34]N/AUCSC Genome Browser tools<http://hgdownload.soe.ucsc.edu/admin/exe/>N/AR/Bioconductor<https://www.bioconductor.org>N/AmetaseqR[@bib25]N/AMACS[@bib50]N/AChIPseeker[@bib48]N/AROSE[@bib53]N/Arecoup<http://bioconductor.org/packages/release/bioc/html/recoup.html>N/AGimmeMotifs[@bib45]N/ASTAMP[@bib24]N/AIn house software<https://github.com/pmoulos/ngs-stone-age>N/A**Other**RNA-seq data[@bib38]E-MTAB-2328H3K27ac ChIP-seq data[@bib29]GSE52386H3K27Me3 ChIP-seq dataMouse ENCODE projectGSE82615 GSE82796\
GSE82458\
GSE83063 GSE31039

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for reagents may be directed to, and will be fulfilled by the Lead Contact Iannis Talianidis (<talianid@imbb.forth.gr>). The mouse lines with liver-specific inactivation of *C/EBPα* gene or *HNF4α* genes (*HNF4α*^*lox/lox*^*/AlfpCre* and *C/EBPα*^*lox/lox*^*/AlfpCre)* generated in this study by crossing of the targeted mice are available without restrictions. No other unique reagents were generated.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Mice {#sec4.3.1}

Liver-specific C/EBPα-KO and HNF4α-KO mice were generated by CRE-loxP-mediated excision of the entire coding region of the *C/EBPα* gene or exons 4 and 5 of the *HNF4α* gene by crossing *C/EBPα*^*lox/lox*^ mice ([@bib11]) or *HNF4α*^*lox/lox*^ ([@bib9]) mice with mice carrying the alpha fetoprotein-*Cre* (AlfpCre) transgene, respectively. Full inactivation occurred between embryonic days 12.5 and 15.5. The RNA-seq and qRT-PCR analyses reported here were performed at E18.5.

Mice were maintained in grouped cages in a temperature-controlled, pathogen-free facility on a 12-hr light/dark cycle and fed by a standard chow diet (Altromin 1324; 19% protein, 5% fat) and water *ad libitum*. All animal experiments were approved by the Institutional Ethical Review Board of IMBB-FORTH and BSRC Al. Fleming, the Prefecture of Attica and the Prefecture of Crete and were performed in accordance with the respective national and European Union regulations. All the experiments were performed in randomly chosen age-matched male mice. Typically, each experiment was performed in tissues from at least 5 individual mice. No blinding was used in this study. Primary hepatocytes from embryonic and adult livers were isolated by collagenase digestion as described in [@bib13].

Method Details {#sec4.4}
--------------

### Chromatin Immunoprecipitation (ChIP) {#sec4.4.1}

Liver tissue was minced to small pieces in PBS and after addition of formaldehyde to a 1% final concentration immediately was subjected to 10 strokes of dounce homogenization. Cross-linking was continued for 10 min and stopped by the addition of glycine at 0.125 M final concentration. Cross-linked cells were treated with a buffer containing 50 mM HEPES pH 7.5, 0.14 M NaCl, 1 mM EDTA, 10% Glycerol, 0.5% NP40 and 0.25% Triton X-100, for 10 minutes and then with a buffer containing 0.2 M NaCl, 1 mM EDTA, 0.5 mM EGTA and 10 mM Tris-HCl pH 8.0 for 5 minutes. The nuclei were resuspended in up to 4 mL with sonication buffer containing 10 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% Na-deoxycholate and 0.5% N-lauroylsarcosine and sonicated for 12 minutes in Covaris Sonicator instrument. After sonication, samples were supplemented with 400 μL of 10% Triton X-100 and centrifuged for 10 minutes at 20.000 r*cf.* After centrifugation, the extracted chromatin was incubated overnight with Dynabeads Protein G, that were prebound by 10 μg of the respective antibodies. The beads were washed six times with a buffer containing 50 mM HEPES pH 7.5, 500 mM LiCl, 1 mM EDTA, 1% NP-40, and 0.7% Na-deoxycholate, and then once with a buffer containing 20 mM Tris-HCl pH 7.6 and 150 mM NaCl. Immunoprecipitated chromatin was eluted from the beads and reverse crosslinked by overnight incubation with a buffer containing 50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 1% SDS, at 65°C. Following incubation, samples were diluted by addition of one volume of TE. RNAs and proteins were removed by incubation with 20 μg/ml RNase A for 30 minutes at 37°C, followed by incubation with 20 μg/ml Proteinase-K for 2 hours at 55°C. DNA was extracted by phenol/chlorophorm and precipitated with ethanol. About 10 ng of the immunoprecipitated DNA and input DNA was used for library preparation.

### ChIP-seq Library preparation {#sec4.4.2}

Libraries were prepared using TruSeq or NEBNext Adaptors, depending on whether less or more than 6 indexes were included. In all cases, 25 μL of immunoprecipitated DNA was purified using the MinElute columns (QIAGEN, 28604) and eluted with 10 ul elution buffer. The concentration of the eluted DNA was measured in Qubit using the dsDNA HS Assay Kit (Invitrogen Q32851). Subsequently, ten ng of ChIP or input DNA were subject to end repair, in a mix containing T4 DNA polymerase (NEB M0203L), Klenow fragment (NEB M0210L), T4 DNA PNK (NEB M0201L) and dNTPs in T4 DNA Ligase Buffer (NEB, B02025) at 20°C for 30 min. Following end repair, samples were purified using the Agentcourt AMPURE XP system (Agentcourt A63881) and subject to A addition by incubation with dATP and Klenow 3′→5' exo- 37°C for 30 min. Another AMPURE XP purification was performed and then Truseq or NEBNext adaptors were ligated using Quick Ligase in Quick Ligase Buffer. Following adaptor ligation, samples were incubated with 1.5 ul USER enzyme at 37°C for 15 minutes, to cleave the adaptor hairpin loop. Purification and size selection was performed again by AMPURE XP and PCR amplification was performed using Truseq or NEBnext Primers in Kapa Hifi Hotstart mix. A final purification was performed and libraries were ready for Bioanalyzer assessment and sequencing.

### RNA purification and RT-PCR {#sec4.4.3}

Total RNA was prepared by homogenizing liver pieces in 10 volumes of Trizol reagent followed by the addition of 2 volumes of chlorophorm and centrifugation at 12000 g for 15 minutes. The aqueous phases were precipitated with isopropanol. Following resuspension in water RNAs were subjected to additional precipitation with ethanol. The RNA samples were digested with 10 units of DNase I for 10 min at 37°C, followed by purification with phenol/chlorophorm extraction and ethanol precipitation. For first strand cDNA synthesis 1 μg of total RNA was incubated with 200 units of MMLV reverse transcriptase in a buffer containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl~2~, 10mM DTT for 60 minutes at 37°C. Quantitative PCR analyses were carried out in STEP-ONE Real time PCR detection system using Fast Start Universal SYBR Green Master. Primer sequences are shown in [Table S1](#mmc1){ref-type="supplementary-material"}.

### *In situ* immunocytochemistry {#sec4.4.4}

To avoid potential formaldehyde-induced eviction ([@bib8], [@bib44]) of C/EBPα or HNF4α from mitotic chromatin, HuH7 cells were fixed first by incubation with methanol for 15 minutes, followed by 1% Formaldehyde for 10 minutes at room temperature. Cells were blocked with 5% BSA-containing PBS for 1 hour and incubated with the primary antibodies in 1xPBS containing 1% BSA and 0.1% Triton X-100 overnight at 4°C, followed by 3 washings with PBS and incubation with secondary antibodies for 1 hour at room temperature as described in [@bib28]. The coverslips were washed with PBS, incubated with DAPI for 5 minutes and mounted on glass slides using Mowiol and areas containing cells in mitotic phases were observed in Leica TCS Sp8 Confocal microscope.

### RNA sequence analysis {#sec4.4.5}

#### Short read mapping {#sec4.4.5.1}

The RNA-Seq FASTQ files were mapped on the UCSC mm9 reference genome using tophat2 ([@bib52]), with default settings and using additional transcript annotation data for the mm9 genome from Illumina iGenomes <http://cole-trapnell-lab.github.io/cufflinks/>. The ChIP-Seq FASTQ files were also mapped to the mm9 genome using bwa ([@bib51]) with standard parameters. The resulting BAM files were visualized in the UCSC Genome Browser using bedtools ([@bib34]) and by the UCSC Genome Browser toolkit (<http://hgdownload.soe.ucsc.edu/admin/exe>).

Prior to any alignment or further analysis, the quality all the FASTQ files and the reads contained therein was inspected with FastQC (<https://www.bioinformatics.babraham.ac.uk/projects/fastqc>).

#### RNA sequencing analysis {#sec4.4.5.2}

*Differential gene expression*: The raw bam files, one for each RNA-Seq sample, were summarized to an exon read counts table, using the Bioconductor package GenomicRanges. In the intermediate read counts table, each row represented one exon, each column one RNA-Seq sample and each cell, the corresponding read counts associated with each row and column. The exon read counts were filtered for artifacts that could affect the subsequent normalization and statistical testing procedures as follows: if an annotated gene had up to 5 exons, read presence was required in at least 2 of the exons, else if an annotated gene had more than 5 exons, then read presence was required in at least 0.2x⌈E⌉ exons, where ⌈.⌉ is the ceiling mathematical function. After exon filtering, the final read counts for each gene model were calculated as the sums of their exon reads, creating a gene counts table where each row corresponded to an Ensembl gene model and each column corresponded to an RNA-Seq sample. The gene counts table was normalized for inherent systematic or experimental biases using the Bioconductor package DESeq after removing genes that had zero counts over all the RNA-Seq samples. The output of the normalization algorithm was a table with normalized counts, which can be used for differential expression analysis with statistical algorithms developed specifically for count data. Prior to the statistical testing procedure, the gene read counts were filtered for possible artifacts that could affect the subsequent statistical testing procedures.

For the developmental stage data (e15.5, e18.5, P0.5, P4, P14, P22, P60) genes presenting any of the following were excluded from further analysis: i) genes with length less than 500, ii) genes with read counts below the 90^th^ quantile of the counts of the following genes, known to not being expressed from the related literature: Dub1, Gdnf, Gria2, Kcna7, Kcna1, Klf4, Myod1, Myoz1, Myoz2, Nalcn, Nanos1, Nanos2, Nfatc2, Neurod1, Nkx2-1, Nov, Nova1, Nrcam, Phactr1, Phyhip, Ptprn, Ptpro, Rbmy1a1, Scn2a1, Myoc, Mypn, Rlbp1, Ntf5, Bai3, Ttn, Dnahc3, Magea1, Gpc2, Cdh17, Bcl2, Ckm, Slc22a2, Slc22a8, Ucp3, Cidea, Ifng, Tubb3, Olig2, Sox2. The resulting gene counts table was subjected to differential expression analysis using the Bioconductor package DESeq. Differentially expressed genes in at least one condition were identified with an FDR threshold of 0.05.

For the CEBPα KO data genes presenting any of the following were excluded from further analysis: i) genes with length less than 500, ii) genes whose average reads per 100 bp was less than the 25^th^ quantile of the total normalized distribution of average reads per 100bp, iii) genes with read counts below the median read counts of the total normalized count distribution. The resulting gene counts table was subjected to differential expression analysis using the Bioconductor package DESeq. Differentially expressed genes were identified with an FDR threshold of 0.05 and a fold change threshold of −1 and 1 (log~2~) scale for up and downregulated genes respectively.

All the analyses and reporting as well as Multidimensional Scaling (MDS) analysis were performed within the Bioconductor package metaseqR ([@bib25]).

#### ChIP sequencing data analysis {#sec4.4.5.3}

*Peak calling*: For the transcription factor data (CEBPα, HNF4α), the two biological replicates for each developmental stage and their respective DNA input samples were subjected to peak calling using MACS 1.4 ([@bib50]) with the default settings for mouse genome. Prior to peak calling and in order to compensate for differences in library sizes between ChIP and Input DNA sequencing samples, the total number of reads of each sample was equalized by uniformly downsampling reads relatively to the sample with the lower number of reads. The putative binding sites returned by MACS were further filtered for artifacts by i) imposing an additional MACS FDR threshold of 0.1%, ii) excluding peaks demonstrating a fold enrichment less than 1 in log~2~ scale (where fold enrichment is the ratio of reads under a peak area in the ChIP sample to the respective number of reads in the Input DNA sample). This procedure resulted in two sets of peaks for each developmental stage. Next, each twin peak set was combined to a unique set of peaks as follows: i) the genomic coordinates of each pair were intersected to produce a unique peak location, ii) extremely short and extremely long peaks were identified based on the 0.1 and 0.99 percentiles and excluded from further analysis as peak calling artifacts, iii) new peak summits were calculated based on the ChIP signal coverage under the new peak areas from the respective BAM files, iv) in order to be later able to perform reliable motif analysis, any remaining peaks with length less than 150bp were extended to 150bp using their summit location as an anchor point, v) the supporting reads under each peak area were recalculated using ChIP and Input sequencing samples and peaks not respecting the fold enrichment of 1 in log~2~ scale were excluded from the final unified peak set for each developmental stage.

#### Further peak analysis {#sec4.4.5.4}

Peak location analysis was performed with the Bioconductor package ChIPseeker ([@bib48]). Peak proximal to genes were identified using an in-house Perl script (<https://github.com/pmoulos/ngs-stone-age/blob/master/perl/hyperassignpeaks.pl>) within a −10kb to +1kb area from the TSS. All other computations with respect to the final peak sets were performed using R and Bioconductor facilities. The kernel density plots were calculated using peak signals, scaled as Reads per Peak Length per Million converted to the natural logarithmic scale. All calculations were performed using R and Bioconductor facilities. Our kernel density calculator can be found online (<https://github.com/pmoulos/ngs-stone-age/blob/master/R/tfKernelPlot.R>).

#### H3K27ac enriched regions {#sec4.4.5.5}

H3K27ac enriched regions were retrieved from Gene Expression Omnibus (accession [GSE52386](ncbi-geo:GSE52386){#intref0080}) and directly used in the analyses described in the main article as well as for super enhancer identification. For the detection and composition (stitching) of the latter, we used the ROSE algorithm ([@bib47]), with the default parameters apart from the distance from the TSS to exclude from stitching which was set to 2.5kb.

#### H3K27Me~3~ analysis {#sec4.4.5.6}

For H3K27me3 analysis ChIP-Seq data were retrieved from Gene Expression Omnibus (accessions [GSE82615](ncbi-geo:GSE82615){#intref0085}, [GSE82796](ncbi-geo:GSE82796){#intref0090}, [GSE82458](ncbi-geo:GSE82458){#intref0095}, [GSE83063](ncbi-geo:GSE83063){#intref0100} and from [GSE31039](ncbi-geo:GSE31039){#intref0105} the sample GSM1000150). After alignment to the reference genome, all samples were normalized by random donwsampling to the smallest library size and read counting was performed over 11 kb regions (−10kb upstream and +1kb downstream of the TSS). Read counts were then normalized by the region size and the resulting measurement matrix was used to plot H3K27Me~3~ profile data.

#### Mutlidimensional Scaling {#sec4.4.5.7}

In order to perform Multidimensional Scaling analysis for each transcription factor and developmental stage, all the aforementioned identified peak locations were merged for each transcription factor separately, in order to create a genomic coordinates pool, suitable for counting reads for each developmental stage and biological replicate and thus create a read count matrix to be subjected to multidimensional scaling. All calculations were performed using R and Bioconductor facilities.

#### Signal coverage profiles {#sec4.4.5.8}

All average coverage profiles were calculated and visualized with the Bioconductor package recoup (<https://bioconductor.org/packages/release/bioc/html/recoup.html>). Briefly, for coverage profiles across gene bodies, as the latter have different lengths, the gene bodies were split in 200 bins of dynamic length each (so that all genes are split in the same number of bins). Then, the ChIP-seq signal was calculated as normalized (from normalized BAM files, see 'ChIP-seq analysis' above) coverage per base-pair for each bin and averaged per bin, resulting in 200 data points for each gene body, comprising the binding pattern for each gene. For coverage profiles across the TSS, the ChIP-seq signal was calculated as normalized coverage per base-pair.

#### Regulatory score analysis {#sec4.4.5.9}

In order to determine the gene expression regulatory potential of each transcription factor during each developmental stage, the TIP method ([@bib3]) was used. Briefly, TIP constructs a transcription factor regulatory score distribution based on a statistic which is calculated by integrating and averaging total transcription factor binding profiles around a broad region from the TSS, thus taking into account specific binding characteristics including signal height and spread. The statistical significance of the TIP regulatory score is assessed using the standardized normal distribution (Z-scores). The regulatory score was calculated over a region of 10kb upstream and 1kb downstream of the TSS. To illustrate the potential correlation between the regulatory scores and the respective gene expression across developmental stages, the ranked regulatory score distribution was plotted against the Reads Per Gene Length (RPGL) distribution from the respective RNA-Seq data sorted according to the regulatory score ranking. The RPGL for each gene is the ratio of its DESeq normalized read count value to the sum length of its exons. The RPGL distributions were smoothed using smoothing splines in R. The implementation of the TIP method can be found online (<https://github.com/pmoulos/ngs-stone-age/blob/master/R/TIP.R>).

#### Motif discovery {#sec4.4.5.10}

The coordinates of all the TF peak maxima located in a region from 1 kb upstream to 1kb downstream of the TSS, were extended by 250 bp on each side to create 500 bp genomic regions. *De novo* motif search was performed using the GimmeMotifs software suite, which combines several widely used *de novo* motif finding algorithms ([@bib45]) for motif lengths from 6 to 15 bp. The significant motifs were curated and converted to Position Weight Matrices (PWMs), which were clustered and compared against the JASPAR database using STAMP ([@bib24]). The data-driven PWMs were subsequently used to scan TF peak subsets from 1kb upstream of TSS to TSS and from TSS to 1kb downstream for the occurrence of the respective motifs. The significance of the scan was assessed by scanning (using pwmscan from GimmeMotifs) for the motifs of interest against random promoter (10kb upstream to 1kb downstream) sequences of the same length as the input sequences (500 bp) using a Monte Carlo simulation approach, where for each motif the random scanning was repeated 1000 times. The statistical significance was assessed using the bootstrap p value:$$p_{i}^{b} = \frac{\#\left\{ {motif\ i\ background\ matches \geq motif\ i\ matches\ in\ TF\ peaks} \right\}}{n}$$where *n* is the number of random background sequences and *i* the motif for which scanning was performed. $p_{i}^{b}$ is a modification of the estimation of the Achieved Significance Level for bootstrap.

#### Pathway Analysis {#sec4.4.5.11}

Gene Ontology (GO) enrichment and biological pathway analyses were performed by using g:profiler R-package tool (<https://biit.cs.ut.ee/gprofiler/gost>) with g:SCS multiple testing correction method applying significance threshold of 0.05 ([@bib35]).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Statistical tools used for the analyses of ChIP-seq, RNA-seq data, motif search and pathway analyses can be found within the respective software packages described above. Statistical significance of the ChIP-qPCR and RT-qPCR data was determined by two-tailed Student's t test using GraphPad Prism.

Data and Code Availability {#sec4.6}
--------------------------

The ChIP-seq data for C/EBPα, for HNF4α and for RNA Pol-II, as well as the RNA-seq data for C/EBPα-KO and HNF4α-KO generated during this study are available at the GEO (Gene Expression Omnibus) database under Accession Code: GEO: [GSE137066](ncbi-geo:GSE137066){#intref0125}. Data for H3K27ac analyses were retrieved from GEO: [GSE52386](ncbi-geo:GSE52386){#intref0130}. Data for H3K27Me3 analyses were retrieved from GEO: [GSE82615](ncbi-geo:GSE82615){#intref0135}, GEO: [GSE82796](ncbi-geo:GSE82796){#intref0140}, GEO: [GSE82458](ncbi-geo:GSE82458){#intref0145}, GEO: [GSE83063](ncbi-geo:GSE83063){#intref0150}, and GEO: [GSE31039](ncbi-geo:GSE31039){#intref0155}. The RNA-seq data were retrieved from E-MTAB-2328.
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